US Patent 12024569 HER2/neu-specific antibodies and methods of using same
Patent 12024569 was granted and assigned to MacroGenics on July, 2024 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 12024569 HER2/neu-specific antibodies and methods of using same
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
